Science topic

Antibodies - Science topic

An antibody, also known as an immunoglobulin, is a large Y-shaped protein produced by B-cells that is used by the immune system to identify and neutralize foreign objects such as bacteria and viruses. The antibody recognizes a unique part of the foreign target, called an antigen.
Questions related to Antibodies
  • asked a question related to Antibodies
Question
2 answers
Dear community,
I want to perform an analysis of the risilin localization within the legs of myriapods and would like to visualize the localization of the resilin components in different taxa.
Do you have any recommandations for a commercial antibody (doesn't matter if its mono- or polyclonal))
Thank you very much.
Best,
Benjamin
Relevant answer
Answer
Suggestion along this line
Best regards
Thies
  • asked a question related to Antibodies
Question
5 answers
I have two antibodies that are staining well in IHC but not in IF for tissue sections, when using the same concentration and antigen retrieval method for both. I also know the secondary works well.
Relevant answer
Answer
Hello immunohistochemistry IHC can create primary and secondary antibodies,hope you know thermo fisher apats enough wit your role protocol , serially
Fix freshdisseccion overnight
Rinse with running tap water
Dehydrated the tissue 4 times of 100pp alcoholic
So on
But b cells
When immune fluorescence if uses fluorescence signal not for both like faded straining when IHC staining is parmanent and not faded
  • asked a question related to Antibodies
Question
3 answers
I want to deplete (negative depletion) all T-cells and NK cells from human buffy coat PBMC using three antibodies: CD3-PE, CD16-PE and CD56-PE and anti-PE magnetic beads. Can I do that by mixing the antibodies and following the standard protocol? How to calculate how much antibodies and beads do I need? How to calculate the yield of total cells I would get in the flow-through? I'm assuming around 30-40%?
If anyone has ever had a similar problem I would really appreciate it if you shared your experience.
Relevant answer
Answer
Just some advice from experience- Don't use PE labeled antibodies for depletion. When I did this I consistently saw incomplete depletion despite titration of antibody and bead concentrations. Our miltenyi rep recommended using streptavidin (best) or APC-conjugated antibodies for depletion since there are more bead-binding sites per molecule (4-7 biotin molecules/antibody, and APC is dimeric with 2 sites). PE labeling is better for positive selection. Biotinylated antibodies are also generally much cheaper.
  • asked a question related to Antibodies
Question
1 answer
I am wondering what folks have tried for alternative methods of detecting hepatitis B core antigen/capsid. Dako used to make an antibody that was very effective in this and widely used in the field, but since their acquisition by Agilent it is no longer made and there are no validated substitutes. We have already spoken to Agilent and checked Biocompare, and while several similar-sounding ones seem to exist, they all lack references or any figures showing that they work for western blots. All publications using immunoassay detection of this protein still use the Dako antibody. Has anyone found another antibody that works, even if you're not publishing with it yet?
Relevant answer
Santa Cruz Biotech has a variety of anti-HBcAg monoclonal antibodies. We use sc-23946 for detection by ELISA. This seems to be similar to the old 222-1 monoclonal and recognizes an epitope at HBc aa120-140. We use this antibody in ELISA detection and it appears to well-exposed on intact HBcAg particles as well as on denatured particles. You can message me if you would like to know more.
  • asked a question related to Antibodies
Question
2 answers
As title describes, we're trying to mutate an amino acid of antibody Fc to cysteine, followed by TCEP to further drug conjugation, one of my colleague had raise the concern of purified TCEP treated antibody might be affected by the tris that had been used to store the protein. Is it possible? and if yes, what might be the reason?
Relevant answer
Answer
No. Tris is a problem with succinimide conjugation, but it won't affect maleimide conjugation. You may expect TCEP to reduce most or all Cys in the Ab, not only your newly introduced residue. So you may observe multiple coupling, especially in the hinge region. Degas and avoid aeration, as Cys undergoes facile air oxidation.
  • asked a question related to Antibodies
Question
1 answer
I am working on Exosomes that is derived from cells that are engineered to express scFv of Anti-HER2 antibody. I want to see its expression in TEM. Can I directly label the exosomes with the Protein L-GNP or do I need to use Anti-Anti HER2 antibody and secondary antibody then stain with Protein L GNP?
Can anyone suggest literature on Protein L-GNP immuno gold staining in TEM?
Relevant answer
Answer
Please follow MDPI
Journal
Researcher Anirban sengupta and Azharuddin.
  • asked a question related to Antibodies
Question
5 answers
I'm sure that many of you will relate to that experience of having an antibody that is just of bad quality. It creates problems because of cross-reactivity or non specific interaction and it's just impossible to work with, but is what you have or there is no other option but to use it.
So you soldier on, and develop new tricks to work with a fundamentally problematic system.
At what point you say.. "ok, it's enough" and admit defeat?
what is the last card you play before folding?
Relevant answer
Answer
Since a mAb should be a single pure immunoglobulin, if it is cross-reacting with other antigens than the one it is intended to react with, then it means the other antigens have a similar or identical epitope as the intended antigen.
One scenario is that cross-reacting but unrelated antigens interact more weakly with the mAb than the intended antigen, in which case you can improve the specificity by reducing the antibody concentration.
Another scenario is that the cross-reacting antigens are closely related to the antigen of interest and contain the same epitope. It might be worth identifying these other antigens. In some cases, they may be proteolytic fragments of the antigen (lower molecular weight), or products of alternative splicing or gene duplication, or of alternative post-translational modifications. Different levels of glycosylation can result in multiple bands of the same antigen on a Western blot, for example.
  • asked a question related to Antibodies
Question
11 answers
I was wondering if anyone knows an antibody that can be used for staining microglia in zebrafish? I am familiar with 4c4 and L-plastin antibodies, but these are not perfect for me. Is anyone familair with, for example, a P2Y12 ab that works in zebrafish ?
Thanks!
Relevant answer
Answer
Bommana Raghunath Reddy, Anna A. Akopyan Sorry for bothering you; following this thread, I was wondering if I could ask for more details on this antibody from your experience. We recently purchased this antibody, and I've tried it on frozen zebrafish brain (10 um) but haven't seen signals with goat anti-rabbit Alexa 488. I read previous articles that showed a strong signal presentation (for example. ). I'm just curious if there is something I have been missing or if I did it wrong. I tried using citrate as antigen retrieval at 80c for 30 mins (this worked for L-plastin) and 110 c, 16 mins. Was wondering if I could have suggestions from you. Thank you.
  • asked a question related to Antibodies
Question
2 answers
Hi!
I´m currently trying to isolate Mitochondria from HCM cells. For my western blots I need an additional antibody against a mitochondrial protein which is bigger or smaller than 14/17 kDa.
I was thinking of a protein which is only present in mitochondria or in the matrix. Maybe transmembrane proteins (TOM or TIM) will work too, but I don't know if the membranes are still intact in my samples. Maybe proteins from the ß-oxidation? Does someone know which antibodies can be used to detect mitochondrial proteins in western blots? If possible only proteins/Abs that are located/synthesized in the mitochondria (matrix). Thanks a lot!
Relevant answer
Answer
To detect mitochondria in Western blots, you typically use antibodies targeting proteins specific to mitochondria. Here are some commonly used antibodies for detecting mitochondria:
  1. Mitochondrial Marker Antibodies: Mitochondrial membrane proteins: Antibodies against proteins located in the mitochondrial outer membrane (e.g., Tom20, Tom22) or inner membrane (e.g., Tim23, CoxIV). Mitochondrial matrix proteins: Antibodies against proteins localized within the mitochondrial matrix (e.g., Hsp60, Citrate Synthase).
  2. Mitochondrial Respiratory Chain Complex Antibodies: Antibodies targeting subunits of mitochondrial respiratory chain complexes (Complexes I-V). For example, antibodies against subunits of Complex I (e.g., NDUFA9), Complex II (e.g., SDHA), Complex III (e.g., UQCRC2), Complex IV (e.g., COXIV), and Complex V (e.g., ATP5A1).
  3. Mitochondrial Transporter Proteins: Antibodies against proteins involved in mitochondrial transport processes, such as the mitochondrial ATP/ADP translocase (ANT), the voltage-dependent anion channel (VDAC), or the mitochondrial calcium uniporter (MCU).
  4. Mitochondrial Fission/Fusion Proteins: Antibodies against proteins involved in mitochondrial dynamics, such as dynamin-related protein 1 (Drp1) for fission or mitofusins (Mfn1 and Mfn2) for fusion.
  5. Mitochondrial DNA (mtDNA) Antibodies: Antibodies targeting mitochondrial DNA-encoded proteins, such as cytochrome c oxidase subunit I (COI) or cytochrome b (Cytb)...When selecting antibodies for mitochondrial detection in Western blots, consider factors such as antibody specificity, sensitivity, and validation in the context of your experimental system. Additionally, it's essential to include appropriate controls and validate antibody specificity through techniques like immunofluorescence, immunocytochemistry, or knockout/knockdown experiments if available.
  • asked a question related to Antibodies
Question
3 answers
We received a limited amount of an antiserum antibody as a gift from another lab and are trying to avoid having to purify it. Our initial titration blot with blocking in 5% milk successfully detected the target protein, but encountered significant non-specific binding likely from high albumin-IgG in the serum.
Would using BSA for blocking decrease the non-specific binding, or could it exacerbate the issue due to additional albumin from the BSA? We have never performed westerns with unpurified antiserum antibodies before so any help or tips would be appreciated!
Edit: This is NOT a phospho-specific antibody
Relevant answer
Answer
I think nonfat dry milk milk and BSA (1-5% each) work equally well as blocking agents for Western blots. Milk is much less expensive than BSA. Use the name brand (Carnation) if it's available.
I'm not sure what you mean by "additional albumin from the BSA." BSA is albumin. The blocking agent in milk is casein. You can also by protein-free blocking agents, which are expensive but useful when you are using strepatividin-based detection, since biological blocking agents can contain biotin.
A good way to remove unwanted immunoglobulins when you only have a little antiserum is to affinity purify on a micro scale. Preincubate a small amount of the antiserum with a sample containing the unwanted antigens but not the desired antigen, if such a sample is available or can be prepared.
  • asked a question related to Antibodies
Question
4 answers
Aslamo alikom/ Greetings everyone,
I'm conducting a western blot experiment (8% SDS gel) and I wanna test 2 proteins, one is 95 KDa, and another is 35KDa. The antibodies I've for both are mouse Abs used at 1:1000 dilution and I use secondary HRP-conjugated at 1:2000 dilutions.
Ideally, I use to test them sequentially, but I'm wondering if it's possible to add the 2 antibodies to the incubation buffer (BSA/milk) and test for both in one go?
I would highly appreciate an answer for this. Also, if someone has done it before, I would appreciate the feedback/tips if any.
Thank you
Relevant answer
Answer
Dear Mariam,
It is advisable not to mix two primary antibodies even if they have requirement for same secondary antibody. Cutting the blot based on the molecular weight is one approach and the second one is to follow sequential incubation.
Good luck with your blots.
Best,
Sheethal Galande
PhD Fellow
AHF
AIG Hospitals
  • asked a question related to Antibodies
Question
4 answers
I am working on heterologous sandwich lateral flow assay.
I conjugate one antibody with carboxyl-gold, then print the other antibody on the nitrocellulose membrane.So the antigen should bind to the first antibody, then immobilize by the second antibody.
Even the two antibodies do not bind to each other, I always get two positive bands at the test line and control line when there is no antigen.
Different blocking condition(BSA%) and running buffer was tried, but I still see false positive band.
Is there any explanation or solution to this problem?
Relevant answer
Answer
is it is a strong signal, I would say that you should change the antibodies.
If it is a very faint signal, the blocking the NC or reducing the concentration of the gold conjugate could help.
If it is not really cross reaction or non-specific interaction, then explore the possibility that you have a stability problem in the conjugate that is damaging the antibody
  • asked a question related to Antibodies
Question
1 answer
Hello. TetraHis antibodies recognise 4xHis-tag in the protein. What if I have a long His-tag (e.g. 10xHis-tag) and I perform ELISA or Western Blot based on native PAGE? Is there a chance that two TetraHis antibodies will sometimes bind to the long His tag and I'll get a false signal increase? Or is the potential distance between the antibodies too small and therefore after the first molecule has bound, the second molecule won't be able to approach the His-Tag, and it will be always 1 binding per 1 protein?
I started to think about it because the manufacturers of precoated well plates indicate the amount of histidines in the tag of the target protein. Is it possible that they imply potential overbinding?
Thanks.
Relevant answer
Answer
Hello, on my oppinion, if you are only working with that "long"Histag protein, is not relevant how manny antibodies are allowed to bind to the tag, because they are to bind the same amount (mean) to each singular protein.
You have to realized that your are not working with 1 single protein molecule, you have thousands units of your protein, so what you are measuring is the average of thousands signals (including the one with pottentialy 2 bind Ab and the one with 1 binded Ab). So yes, i think that if you are measuring a signal increase, it is a real increase in what you are measuring.
I hope this help you
Greetings
  • asked a question related to Antibodies
Question
4 answers
i am working with membrane protein and there is a his tag 4 amino acid above the c terminus (seq HHHHHHDLEY). anti his antibody does not recognise the his tag in western blotting. i was wondering if it is necessary for his tag to be on N or C terminus for western blotting and purification
Relevant answer
Answer
As already said the position in the sequence is not essential for detection in western blot.
However if you want to know which teminus is better for purification, you can use alphaFold2 prediction to check wich terminus is exposed and tag accordingly.
  • asked a question related to Antibodies
Question
1 answer
We have constructed lentivirus transduced U251 cell lines to express (1) EGFRvIII (its amino acid sequence is MRPSGTAGAAFLALLAALCPASRALEEKKGNYVVTDHG..., which is identical to the sequence described in https://www.addgene.org/20737/)-mCherry or (2) EGFRvIII_G38C(MRPSGTAGAAFLALLAALCPASRALEEKKGNYVVTDHC...)-mCherry.
Both types of cells did not yield positive results by using antibodies against LEEKKGNYVVTDHC (https://www.novusbio.com/products/egfr-antibody-dh83_nbp2-50599af647).
The (2) EGFRvIII_G38C-U251 cells have not been tested by 2-step staining.
We are curious about this question. Have you met problems when dealing with EGFRvIII?
Relevant answer
Answer
Antibodies against EGFRvIII, a variant of the epidermal growth factor receptor (EGFR) that is commonly found in certain types of cancer, may not work effectively for several reasons such as Tumor Heterogeneity, Immune Evasion Mechanisms, Resistance Mechanisms, Blood-Brain Barrier, Inadequate Targeting.
  • asked a question related to Antibodies
Question
1 answer
Prior to the research carried out by the research group who published this journal, they assessed HDV RNA detection's diagnostic efficacy utilizing the HDV RNA detection technique and discovered that it had a good diagnostic yield. However, HDV serology's diagnostic effectiveness hasn't been thoroughly assessed and documented, thus, the need to consider the factors needed in developing a reliable serological test for HDV antibodies.
Relevant answer
Answer
Developing a reliable serological test for HDV antibodies that can effectively account for diverse genotypes requires careful consideration of several factors:
  1. Antigen Selection: Identifying antigens that are conserved across different HDV genotypes is essential to ensure the test's effectiveness across various strains. Antigenic regions that are highly conserved among different genotypes would be preferable for maximizing test sensitivity.
  2. Cross-Reactivity: Assessing potential cross-reactivity with antibodies from other related viruses, such as hepatitis B virus (HBV), is crucial to avoid false-positive results. HDV commonly infects individuals with HBV, so distinguishing between antibodies to HDV and HBV is important for accurate diagnosis.
  3. Genotype-Specific Detection: Developing assays capable of detecting genotype-specific antibodies can provide valuable information about the specific HDV strain present in an individual. This may involve incorporating genotype-specific antigens or optimizing assay conditions to enhance genotype discrimination.
  4. Sensitivity and Specificity Optimization: Ensuring high sensitivity to detect even low levels of antibodies and high specificity to minimize false-positive results is critical for the reliability of the test. This may involve optimizing assay parameters, such as antigen concentration, incubation time, and detection methods.
  5. Validation with Diverse Patient Samples: Testing the serological assay with a diverse range of patient samples, including those infected with different HDV genotypes and individuals with co-infections (e.g., HBV/HDV), is necessary to validate its effectiveness across various populations.
  6. Quality Control Measures: Implementing robust quality control measures throughout the development and manufacturing process is essential to ensure the consistency and reproducibility of the test results.
By carefully considering these factors, researchers can develop a serological test for HDV antibodies that effectively accounts for the diversity of HDV genotypes and provides accurate diagnostic information. This can significantly improve our ability to diagnose and manage HDV infections in clinical settings.
  • asked a question related to Antibodies
Question
1 answer
Based on the systematic review and meta-analysis of Zhenzhen Pan et al. (2023) on the efficacy of serological antibody detection tests on Hepatitis Delta Virus, they concluded that detection of IgM or IgG is a better choice in HDV diagnosis compared to total antibodies, since total antibody pooled consistently lower specificities. In line with this result, can this limitation be addressed now by more recent or standardized serological tests?
Relevant answer
Answer
Greetings Ms. Baclor,
According to the study, the reported lower specificity of anti-ADV total antibodies is 0.71, while the reported specificity of anti-HDV IgM is 0.98 and the reported specificity of anti-HDV IgG is 0.96. With these factors in mind, the development of more sophisticated serological tests will be addressed. The current serological tests are adequate for the specificity with IgM and IgG; however, the total antibodies need to be addressed and tested again for improved results. Some potential avenues for its enhancement include enhanced assay development, enhanced test standardization, integration of multiple markers, validation studies, and continuous monitoring and enhancement. By implementing these strategies, researchers and healthcare professionals can contribute to the development of more precise and dependable serological tests for detecting hepatitis delta virus infection, potentially mitigating the difficulties associated with lower specificity of anti-HDV total antibodies.
Reference: Diagnostic Efficacy of Serological Antibody Detection Tests for Hepatitis Delta Virus: A Systematic Review and Meta-Analysis by Zhenzhen Pan et al. (2023)
  • asked a question related to Antibodies
Question
1 answer
I've received antibodies diluted in P.B.S. instead of 5% BSA in 1X T.B.S.
Will this dilution work for IHC or I've to discard the dilution ?
Relevant answer
Answer
Hello Jagtar Singh,
Primary antibody dilution buffer contains 1X TBS, 0.1% Tween-20 with 5% BSA.
Generally, TBS is recommended since the phosphorus within the PBS will interfere with the interaction between phosphorylated proteins and its cognate phosphospecific antibodies.
BSA is used as a carrier protein to dilute antibodies and as a general protein-blocking agent in immunoassays and immunodetection protocols. Also, there is a possibility that antibody may get adsorbed on the surface of the vial making it less available for immunodetection as a result of which one may obtain weak signal. So, BSA is used to prevent surface binding of the antibody and therefore forms an important component of the antibody dilution buffer.
You will have to discard the antibody diluted in PBS as it is likely to give you high background as well as low signal for your target protein. But I would suggest you use this diluted antibody and compare the results with the antibody diluted in (1X TBS, 0.1% Tween-20 with 5% BSA).
Best.
  • asked a question related to Antibodies
Question
1 answer
The cross-match test is an in vitro test to determine the presence of anti-lymphocyte antibody to donor cell antigens (lymphocytotoxic antibody) in serum of an individual with preformed antibodies to donor cells. Examples are recipients for an organ transplant or a couple with a history of recurrent spontaneous abortions. The recipient serum is incubated with donor lymphocytes and the binding can be detected by flow cytometry analysis (with fluorescent conjugated reagent). If cytotoxic antibodies are present in maternal serum, they will combine with the surface antigens of donor lymphocytes; the amount of fluorescence on the cells (percentage of positive T or B cells), as measured by flow cytometry, is proportional to the amount of antibody (flow cytometry cross-match).
Relevant answer
Answer
I would suggest using mouse anti-CD3 and CD19 labeled with fluorescence (FL1) for B and T cells, while using a anti-human Fc labeled with a different FL2 to evaluate the pre-exist anti-lymphocyte antibody. It will be a consecutive gating of first gate is SSC/FSC, second gate is FL1/FL2, while double positive cells are what you want.
Best
  • asked a question related to Antibodies
Question
2 answers
I want to conjugate my antibody with Dylight-NHS ester and corboxylated fluorescent PS beads. How do I check whether both Dylight-NHS ester and corboxylated fluorescent PS beads coupled with my antibody?
Relevant answer
Answer
Conjugating antibodies to DyLight-NHS ester and carboxylated fluorescent Polystyrene beads involves several key steps:
  1. Preparation of Antibodies and DyLight-NHS Ester: Dialyze antibodies if necessary and determine their concentration. Prepare fresh DyLight-NHS ester working solution.
  2. Conjugation with DyLight-NHS Ester: Mix antibodies with DyLight-NHS ester, incubate, and terminate the reaction with a quenching solution.
  3. Purification of Conjugated Antibodies: Remove unreacted reagents using size-exclusion chromatography, dialysis, or spin columns.
  4. Preparation of Carboxylated Fluorescent Polystyrene Beads: Resuspend beads and determine their concentration.
  5. Conjugation with Carboxylated Beads: Mix purified DyLight-conjugated antibodies with beads, incubate, and block non-specific binding.
  6. Washing and Resuspension of Beads: Pellet beads, wash to remove unbound antibodies and blocking agents, and resuspend in buffer.
  7. Characterization of Conjugates: Quantify concentration and confirm conjugation efficiency and specificity using appropriate assays.
  8. Storage and Validation: Store conjugated antibodies and beads appropriately and validate their performance in immunoassays or flow cytometry.
  • asked a question related to Antibodies
Question
3 answers
I would like to enhance the fluorescent signal of mRuby3 in brain slices. I have only found antibodies good for WB. Did anyone try them on tissue? Is there a good antibody for IHC?
Relevant answer
Hi Anna. Did you find a suitable antibody that works ? If so would you mind sharing which one ?
Thanks !
  • asked a question related to Antibodies
Question
7 answers
i am trying to stain different proteins of interest in human paraffinized section.
my signal should be the vessel only, but regardless of the antibody I get circle shaped spots , I tried antigen retrieval with trypsin, and I tried different dilution of antibodies (1:100-1:1000) and blocking in 5% and 10% donkey serum
why I have those spots? how can I reduce them? I have the same issue at different wave lengths (regardless of secondary antibodies tag)
this is my protocol:
•Thickness of sections : 10µ
•Deparaffinization by heat 55degrees for 20 min then (xylene - xylene: ethanol - ethanol) 10min each*twice
•Hydration (ethanol 95% - 70% - 50% - tab water) 5min each*twice
•Antigen retrieval : citrate buffer 10min microwave then leave in buffer to cool
•Peroxide treatment: 3%H2O2 10min at room temp
•Blocking: 5% Donkey serum + 0.3% Triton-PBS 1 hr RT
•Antibodies:
•Primary in 1%BSA: VWF (1:200)
•Secondary 1:500 of Rabbit 594
Relevant answer
Answer
hello all,
Just an update, and for future researchers. I ended up doing multiple steps to decrease the background
1- sodium borohydride (1mg/ml in PBS over ice) for 30 min, refreshing it every 10 min
2- 3% H2O2 for 20 min
3- Sudan black for 30 min in dark
4- increase blocking to 10%Donkey serum + 0.3M glycine for 1 hr
5- increase washing to 15 min * 3 times after primary and secondary
thank you for your help
  • asked a question related to Antibodies
Question
9 answers
Almost all the microbiology textbooks and relevant research articles mention that Hepatitis B core antigen is not released into the blood of the host. It rather interacts with other core antigen particles to assemble the capsid of the Dane particle. My question is then how the body produces antibodies against HbCAg?
Relevant answer
Answer
Anti-HBcAb (antibodies against hepatitis B core antigen) is produced by the immune system in response to exposure to the hepatitis B virus (HBV). When HBV infects hepatocytes (liver cells), the cells produce hepatitis B core antigen (HBcAg) as part of the viral replication process. HBcAg is not released into the blood in significant quantities; instead, it remains within the infected hepatocytes or is present in viral particles.The presence of HBcAg within infected hepatocytes triggers an immune response in the body. B cells, a type of white blood cell, recognize HBcAg as foreign and start to produce antibodies against it. These antibodies, referred to as anti-HBc antibodies, are then released into the bloodstream. The presence of anti-HBc antibodies can be detected through blood tests and indicates exposure to the hepatitis B virus, either currently or in the past.
  • asked a question related to Antibodies
Question
12 answers
I was looking for an antibody that can block the ligand binding domain of mouse EGFR. Can I use Cetuximab or is it exclusively human-specific?
Relevant answer
Answer
Xinyue Chen , whether or not a tumor cell line overexpressing EGFR expresses exactly the wildtype form of the receptor or a mutated or rearranged receptors depends very much on the exact cell line. My experience in transfecting various EGFR mutants taught me that it is far easier to obtain high levels of overexpression for variants deficient in ligand/activation induced receptor degradation.
Given the large difference in the Cetuximab epitope sequence and the corresponding sequence in the murine receptor, I doubt very much that there is sufficient crossreactivity that the reduced affinity could be overcome by increased receptor and/or antibody concentration.
While the attached paper clearly shows that antibody 7A7 does not react with murine EGFR, they used Cetuximab as control in Immuofluorescence and FACS, and show no detectable binding for Cetuximab on the HPV38 cell line, while the positive control antibody AF1280 shows significant overexpression of the murine receptor in this cell line.
  • asked a question related to Antibodies
Question
4 answers
I don't want to give the mouse peritonitis, but I don't want to lose the antibody with it sticking to the filter either. Thanks!
Relevant answer
Answer
The Sterile filtration of antibodies is to be injected intraperitoneally (IP) into mice for neutralization studies to ensure the absence of microbial contaminants and to reduce the risk of introducing infection or other complications into mice. However, whether this is necessary depends on various factors including the source and handling of the antibody, the experimental setup, and the specific requirements of the study.
  • asked a question related to Antibodies
Question
5 answers
Activation of naive T cells generally requires antigen to be presented by dendritic cells in lymph nodes. Activation of naive B cells generally requires opsonized antigen to be displayed by follicular dendritic cells in lymph nodes.
Thus, it seems that dendritic cells and complement (innate immune system) need to recognize a pathogen before an adaptive immune response can be initiated. Is this always the case?
Relevant answer
Answer
Yes, B and T cells can be raised against pathogens that may not have been initially detected by the innate immune system. The adaptive immune system, comprising B and T cells, is adept at recognizing specific antigens presented by pathogens, even if they initially evade detection by the innate immune system. Once activated, B cells differentiate into plasma cells, producing antibodies targeting the pathogen, while T cells undergo clonal expansion and differentiate into various effector cell types. This adaptive immune response, along with the generation of memory B and T cells, contributes to long-lasting immunity against pathogens, irrespective of their initial evasion of the innate immune system.
  • asked a question related to Antibodies
Question
5 answers
Hello everyone,
I'm quitte at a loss here. I'm using the DYKDDDDK Tag Monoclonal Antibody (FG4R) (Catalog # MA1-91878) from thermofisher and while it works beautifully when I blot against Flag or use it to pull-down Flag tagged proteins. I can't see any signal when I use the same antibody to blot for Flag after the IP. If I use an antibody against the protein itself and not the tag, I have a beautiful signal and the shift due to the tag is clearly visible. When I use the Flag antibody, I have no signal.
Did anyone experience that issue ?
Thank you in advance for your help :)
Wilhelm Vaysse--Zinkhöfer
Relevant answer
Answer
I might be cleaving the part of the peptide the antibody targets?
This can only be confirmed by mass spec analysis (PMF analysis)...
Shifted transition is alone not a reliable way to assess whether the FLAG tag or peptide attached was removed or remained intact. For the peptide cleavage confirmation, bottom-up proteomic is needed to conclude...
How about the conformational (high-order structural alterations) modifications after IP elution which results in the FLAG being stuck into the conserved region? Is it possible to become a steric hindrance for the primary antibody to be bound to the FLAG tag after the IP treatment?
Here are a couple of additional considerations;
1)You may modify the construct and switch the position of the tags. Next, observe the results following the same assay sequence (IP and WB tandemly). This may solve the issue without performing any troubleshooting approaches.
2)Perform experiments in comparison using all denatured and non-denatured conditions to get some hints if the structural variations can affect your experimental outputs.
Emir...
  • asked a question related to Antibodies
Question
4 answers
I am planning an immunoprecipitation experiment using Mouse monoclonal [11C9] to Mannan Binding Lectin/MBL (ab26277) antibody to immunoprecipitate for MBL2 in human serum. There are many protocols online for immunoprecipitation utilising cell cultures, where the recommended amount of cells tends to be 10^6 to 10^7, however not so many that utilise human serum.
Reading online, the optimal total protein load of immunoprecipitation seems to be 1-5 mg/mL, with 0.1 mg/mL being the minimum recommended load. Considering that the normal range for total protein in human serum is 60-83g/L (average: 71.5 g/L), loading 5 mg of total protein for immunoprecipitation would mean I need 69.9 mL. Alternatively, loading the minimum (0.1 mg), I would need 1.395 mL of human serum based on my calculations.
I cannot afford to be using 1.395 mL of human serum in my experiment due to lack of sample volume. I was wondering if anyone can share the amount of human serum they've used for immunoprecipitation before, where it was successful. Thank you in advance.
Relevant answer
Answer
You're correct that Ab often perform quite differently in Western versus ELISA. But it's something you can try.
What makes you think your antiserum works at all? if you have any titer measurement you can use that to estimate a working dilution for IP.
Or you could always just guess. A dilution of 1:1000 should work, if the antiserum is reasonably potent. You may be able to go down to 1/10k or 1/100k.
Follow your local rules for use of human tissue in lab research. I recommend you always heat treat human serum to kill viruses, and then still treat the reagent as potentially infectious. My niece caught HepB from handling a human serum sample is a hospital lab.
  • asked a question related to Antibodies
Question
2 answers
Dear experts and colleagues,
I am facing the ghost test line as shown in the attached photos.
Problems are as follows:
1) The flow was slowed down or stopped at the test line. It could not pass the test line and had to flow beside the test line (the dot).
2) It took time for the test line getting wet.
3) The test line became white (ghost test line)
It seems that the test line became hydrophobic that prevents the flow and interferes with the reaction between the Antibody at test line with the Antigen+ conjugation complex.
I intend to block the membrane by BSA 1%, Tween 20 0.05% in PBS 1X. However, I wonder whether I should immerse the membrane in the blocking solution BEFORE or AFTER dropping the Antibody to the test line? As I understand, I should block before dotting the protein on the membrane but I have read somewhere else that we can do it after immobilizing the protein. Therefore, I would like to confirm it. Please help me. Also, If you have any experiences dealing with these problems, please share your solution if possible. Thank you so much!
Relevant answer
Answer
Do the NCM blocking before immobilizing the protein on it. Block the NCM with same buffer with optimization of BSA and Tween-20 (Increasing or reducing the percentage of concentration) and if you feel it decreased your sensitivity the instead of PBS, use 10mM Phosphate Puffer (KH2PO4). I hope it will resolve your problem.
  • asked a question related to Antibodies
Question
2 answers
I have been using primary unconjugated TH antibody followed by a fluorescence tagged secondary antibody for the noradrenergic neurons of my brain stem sections. Due to some changes in my protocol, I have an idea of using primary conjugated tyrosine hydroxylase (TH) antibody. Is it possible to conjugate TH antibody to fluorescence tag. If so, suggestions on available brands of them will be highly helpful. Thank you!
Relevant answer
Answer
Thank you Adam B Shapiro for the response
  • asked a question related to Antibodies
Question
1 answer
Dear all,
I am in search for ideas for what might cause the following issue:
I have done IHC-IF extensively and wanted to perform stainings on cultured cells now, too. However, I am observing unspecific staining of all primary antibodies tested. It is a mystery to me!
Here are the details:
I am staining murine cell lines that have been fixed with 4% PFA for 10 Minutes.
Protocol (washes performed, but omitted here):
  • No retrieval
  • Blocking for 60 Minutes in PBS with 5% NDS + 0,3%Tx-100
  • Primary AB in PBS + 3% NDS+0,3% Tx-100 over night at 4°C
  • Detection with Donkey anti Primary 1:500 in PBS + 3% NDS (60 Minutes incubation at RT)
Results: Three different cell lines (neuronal, astrocytic, endothelial) all stain equally for the antibodies used (broad variety from different species), e.g. anti-GFAP, anti-GFP, anti-MAP2... Most antibodies tested work well in IHC (some are untested) and - based on the literature - many of them are used in ICC successfully. A control without primary antibody does not show staining, so autofluorescence or unspecific binding of the secondary antibody do not seem to be the issue. The composition of the media the cells were cultured in differ between the lines.
Steps taken so far:
- Used new buffers, aliquots, cells etc.
- I have done a dilution series with two different antibodies:
  • Antibody A should only stain cell Line A and antibody B should only stain cell line B.
  • Both cell lines were stained with both antibodies in 11 dilutions ranging from 1:500 to 1:512K
  • Result: Both stainings A and B do not differ between cell line A and B. One can see that the intensity is clearly reduced with lower concentrations of the primary antibody, but there is signal. This signal is absent in the control without primary antibody.
I have also planned to do a qPCR next week to verify the identity of the cell lines just to be sure, but I am feeling like it is a technical problem. I cannot come up with a reason that makes the specimen "sticky" for different primary antibodies, but not for secondaries. It seems unlikely to me that there is a problem with all primary antibodies tested, especially since they work well in free-floating slices.
Any ideas what might cause it and how to solve it would be very much appreciated!
Henrike
Relevant answer
Answer
Hi Henrike,
You blocked the antigens with donkey serum so in the control group, the secondary antibody won't have non-specific bindings. However, this did not rule out the possibility that the primary antibodies have non-specific bindings. Is it possible to use siRNA or certain approaches to deplete the target protein as a control?
Hope this helps.
Yuning
  • asked a question related to Antibodies
Question
2 answers
Colleagues, good afternoon! We plan to conjugate antibodies with a fluorescent dyes. One source says that it is possible to conjugate anebodies that already have tag in the form of HRP, for example. Another source says this will be ineffective. How do you do this kind of work? Is the dilution of such a conjugate different from the conjugate with horseradish peroxidase?
Relevant answer
Answer
If you attach your HRP using the same conjugation chemistry as the fluorophore then yes, it's possible that the HRP conjugation blocks your fluorophore attachment residues. It is best to choose a different chemistry for the two conjugates. For example, you could attach your fluorophore NHS (N-reactive) and attach your HRP using streptavidin (Fc-reactive). That way they go to different places stay out of each other's way.
  • asked a question related to Antibodies
Question
1 answer
We have the peptide and mRNA sequences; is it possible to create an antibody?
Relevant answer
Answer
You don't really "design" an antibody. You grab your peptide or your mRNA and you vaccinate a critter. Its immune system then designs the antibody for you. Yes it really is possible. About $5k to hire a service to do it all for you, just off the sequences.
  • asked a question related to Antibodies
Question
1 answer
Hello all,
I've been struggling to get good FAP staining on my tissues using fluorescent IHC. I've tried three different antibodies from different companies, but the staining isn't working well. Has anyone used an anti-FAP antibody for human cancer tissues and gotten good results confirmed by a pathologist? Any advice would be helpful. Thanks!
  • asked a question related to Antibodies
Question
1 answer
We have mRNA sequence and peptide sequence if possible design antibody?
Relevant answer
Answer
Designing antibodies involves several approaches aimed at generating antibodies with desired properties, such as specificity, affinity, and functionality. Here are some key methods and strategies used in antibody design:
  1. Monoclonal Antibodies (mAbs) vs. Polyclonal Antibodies (pAbs):Monoclonal antibodies are derived from a single clone of B cells and are highly specific to a single epitope on the target antigen. They are typically produced by hybridoma technology or recombinant DNA technology. Polyclonal antibodies are produced by multiple clones of B cells and recognize multiple epitopes on the target antigen. They are generated by immunizing animals with the target antigen and collecting serum containing a mixture of antibodies.
  2. Antibody Selection:Select the appropriate antibody type (e.g., IgG, IgM, IgA) based on the intended application and desired antibody characteristics. Choose the antibody species (e.g., mouse, rabbit, human) that best suits the experimental system and minimizes potential cross-reactivity.
  3. Antigen Selection and Immunization:Select the antigen or antigenic epitope of interest based on its relevance to the research question or application. Design and synthesize peptides or recombinant proteins representing the antigenic epitope for immunization. Consider factors such as antigenicity, immunogenicity, and conservation of the target antigen when selecting the immunogen.
  4. Hybridoma Technology:Generate monoclonal antibodies using hybridoma technology by fusing antibody-producing B cells (isolated from immunized animals) with immortal myeloma cells to create hybridoma cell lines. Screen hybridoma clones for antibody production and specificity against the target antigen. Expand and characterize selected monoclonal antibody-producing hybridoma cell lines.
  5. Recombinant Antibody Technology:Generate recombinant antibodies using phage display, yeast display, or other display technologies. Construct antibody libraries using synthetic or natural antibody repertoires. Select antibody variants with desired binding properties through iterative rounds of selection and screening against the target antigen.
  6. Antibody Engineering:Engineer antibody fragments (e.g., Fab, scFv, nanobodies) with improved characteristics such as smaller size, enhanced stability, or altered effector functions. Introduce mutations into the antibody variable regions to modulate affinity, specificity, or other binding properties. Conjugate antibodies with labels (e.g., fluorophores, enzymes, nanoparticles) for detection or therapeutic applications.
  7. In silico Antibody Design:Use computational methods such as homology modeling, molecular docking, and molecular dynamics simulations to design antibodies with improved binding affinity or specificity. Design antibody-antigen complexes to predict antibody-antigen interactions and optimize binding interfaces.
  8. Functional Antibody Screening:Characterize antibody function through in vitro assays (e.g., ELISA, Western blot, immunoprecipitation) and in vivo assays (e.g., cell-based assays, animal models). Assess antibody specificity, affinity, and functionality under relevant experimental conditions.
By combining these methods and strategies, researchers can design and generate antibodies tailored to their specific research needs, facilitating a wide range of applications in basic research, diagnostics, and therapeutics.
  • asked a question related to Antibodies
Question
2 answers
The old antibody has been discontinued and the currently offered are detecting a band at 62 kDa, which does not reflect the correct molecular weight (47 kDa).
Relevant answer
Answer
Hi Pietro,
We at Biomatik have some options for you.
You can have a look at our antibodies for Human SQSTM1 here: https://www.biomatik.com/search-results-page?q=Human%20SQSTM1&page=1&rb_categories=Antibodies
We also have a list of over 14,000 high quality catalog antibodies that you can browse.
We look forward to hearing from you soon.
Best regards,
Biomatik Team
  • asked a question related to Antibodies
Question
3 answers
My student optimizes the RNA dot-blot method using a biotinylated cDNA probe. The aim is to detect a positive hybridization signal of a probe complementary to transcripts of a housekeeping gene for Human actin beta in the human RNA samples. So far, we have not been able to detect consistent hybridization signals. Either there were non-specific, very weak or no hybridization signals at all. Above it, we have recently observed a reverse white signal in dot-blot spots with our human RNA after colourimetric detection. The only such phenomenon I found when googling for the solution appears after chemiluminescent signal detection. The alleged ghost bands or spots appear when a sample or antibody excess consumes chemiluminescent substrates too quickly. However, in the case of colourimetric detection, the chromogenic substrate accumulates instead of being consumed, even in the excess of both sample and antibody. In search of a solution, we performed a dot-blot with a matrix of sample and antibody amount combinations, which resulted in either reverse or no signal et all. Does anybody have any idea where the problem could be?
Please, see the attached photo of the dot-blot results. There are 3 membrane strips, the numbers 1, 3, and 5 at each strip indicate the antibody dilution 1:1000, 1:3000, and 1:5000 respectively. The pink strip on the top of the photo shows the identity (and in the case of RNA samples also the total amount) of loaded samples in the indicated order. There are total RNA samples at the concentrations 5 ug, 500 ng, and 50 ng, followed by positive control spots of biotinylated lectin (positive control of colourimetric development of a signal produced by reporter molecule HRP in conjugate with streptavidin) and the rightmost spot is the labelled probe.
I will be very grateful for any suggestions!
Relevant answer
Answer
White residue does usually mean too much signal and the chromophore has been used up but I wonder in your case if the saple has not bound to the membrane but has affected the loading spot so that it is blocked more than the rest of the filter producing no signal.
Samples are usually bound to the membrane in high salt so that everything binds and then the filter is washed at lower salt to get a strong bound signal but also a low background. I would check the type of membrane to ensure good sample binding ( heating the membrane or incubating in NaOH for some nylon membranes) Possibly use a higher salt wash to ensure getting a strong signal but possibly with high backround and if that works then try more stringent washes but getting a positive signal will make troubleshooting easier because negative results can come from many sources...wash temperature.wash or binding salt concentrations or faulty reagents
  • asked a question related to Antibodies
Question
6 answers
Hi all,
We are looking for an antibody that recognises N-terminally tagged His tag on a recombinant protein, any recommendations or where to find this information would be appreciated.
Thank you
Relevant answer
Answer
Hi, maybe you should confirm that it binds only the His-tag and not one or more of the upstream amino acids. Alternatively it could have a specificity towards the carboxy-group of the last His which could explain its preference.
  • asked a question related to Antibodies
Question
3 answers
I am developing a protocol for the generation of antibodies using the Phage display method. Could anyone share a protocol for bio panning of biotinylated antigens?
Relevant answer
Answer
Thank you Thomas.
  • asked a question related to Antibodies
Question
3 answers
I would like to know if it is possible to use antibodies (in this case I would like to use two markers of neutrophils and monocytes such as FITC anti-mouse Ly-6G and FITC anti-mouse Ly-6C) whose application is referred only to cytometry for visualization in confocal microscopy.
Relevant answer
Answer
In general, if antibodies work in tissue (confocal), they should always work in cell suspension (flow cytometry), but not vice versa.
Reasons are below:
1. Epitope availability. Some epitopes on the protein target might be blocked in tissue that cannot be accessed by antibodies using the same epitope. Then you may need to go through the "finding the right clone" process to make it work in tissue.
2. Fluorophore limitation. Many scopes are limited by the choices of laser they have, most don't have UV laser in 350nm, therefore you can't use BUV dye conjugated antibodies. BV dyes can be excited at 405nm but they are large polymer dye that may not be staining complex cell processes and tissue structures as well as small dyes such as Alexa Fluor dyes. Many flow antibodies are designed in these colors and not available in other dyes such as BD antibodies, while many tissue antibodies are limited in colors.
  • asked a question related to Antibodies
Question
1 answer
Hello¸
Im PhD Student in UQTR ( Canada), I have a crucial experience for my project thesis : I have a WB (western blot) membrane that I need to store for a long time for incubation with other antibodies (Precisely Ubiquitin) . I read that I can put it in a bag at -20C.
I want just to confirm if I did it correctly (see picture) or there are other ways.
Thanks in advance
Ayoub
Relevant answer
Answer
I usually air dry the membranes after dipping in methanol and seal it in a plastic bag at -20 degree celsius.
  • asked a question related to Antibodies
Question
1 answer
I want to specifically block a GPCR on cell membrane (also has mitochondrial distribution), but all commercially avaible drugs are cell permeable. therefore, I was seeking to use antibody to block the GPCR located at the cell surface. The antibody i used can identify the protein by surface staining during flow cytometry and also can pull down my target protein by immunoprocipitation, does that means this antibody can block the extracelluar region of this protein and be used for my purpose?
Relevant answer
Answer
It is possible that it can be used for this purpose. If I am understanding correctly, you will likely need to search the literature to find an antibody clone which specifically blocks the extracellular binding pocket, search through commercially available clone descriptions about epitopes which may block the binding pocket, or use trial-and-error to test antibodies that could block the GPCR. The one which you describes might work since it is apparently targeting the extracellular region of GPCR, but you'd need to test it to find out. If you test your antibody and find that it does not block GPCR, it most likely means that the antibody is binding another region of GPCR that's farther away from the binding pocket.
  • asked a question related to Antibodies
Question
1 answer
I am trying to detect CCK in plasma with the antibody. if anyone knows how to detect and how much to load.
Relevant answer
Answer
In plasma due to the presence of too many proteins (with albumin constituting nearly half of it), it would be difficult to detect CCK, especially if it has a low expression. Moreover, you are likely to get high background due to the presence of other proteins.
I would recommend the use of Immunoprecipitation method, a method that enables the purification of your protein of interest. An antibody for target protein is incubated with plasma enabling the antibody to bind to the protein in solution. The antibody/antigen complex is then pulled out of the sample using protein A/G-coupled agarose beads. This isolates the protein of interest from the rest of the sample. The sample can then be separated by SDS-PAGE for western blot analysis.
The Immunoprecipitation protocol is provided in the link below.
Best.
  • asked a question related to Antibodies
Question
2 answers
The detailed Western Blot procedure
The membrane is first rinsed briefly with 20ml of TBS, followed by a 30-minute incubation, shaking with 10ml of Blocking Buffer. During this incubation, the volume of primary antibody needed for a 1:5000 dilution into 10ml of blocking buffer is calculated, and 10ml of blocking buffer is prepared for the antibody. Subsequently, the Blocking Buffer is removed, and the membrane is incubated for 45 minutes, shaking with 10ml of primary antibody in Blocking Buffer (Rabbit anti-ADH diluted 1:5000). After removing the antibody, the membrane is washed three times for 5 minutes each with 10ml of Blocking Buffer. Meanwhile, a 1:5000 dilution of the secondary antibody in 10ml of blocking buffer is prepared. The membrane is then incubated for 45 minutes, shaking with 10ml of secondary antibody in Blocking Buffer (Alkaline Phosphatase conjugated Goat anti Rabbit diluted 1:5000). Following the antibody removal, the membrane undergoes three 5-minute washes with 10ml of TBS/T. Finally, 5ml of BCIP/NBT liquid substrate (Sigma-B1911) is added, and incubation continues until color develops, with the reaction being stopped by rinsing with distilled water.
I was told I might have washed it with a different TBS (10mM one instead of 5mM)
What could the reason for such a different bands on the well.
Relevant answer
Answer
Some possible reasons for seeing extra bands are (1) insufficient blocking, (2) an insufficiently specific primary antibody, (3) too high a concentration of the primary antibody, (4) insufficient quality of the antigen, containing multiple aggregates and proteolytic fragments.
Check by SDS-PAGE if the supposedly purified antigen runs as a single band using a heavy loading to see minor bands.
  • asked a question related to Antibodies
Question
2 answers
I am hoping that someone can help me find an antibody for GABA, GAD 65 or GAD 67 that works well in marmoset cerebral cortex
Thanks
Relevant answer
Answer
Anti-GAD65 + GAD67 antibody [EPR19366] (ab183999)
Reviews (4) Specific References (8)
Description:
Rabbit monoclonal [EPR19366] to GAD65 + GAD67
Application:
ICC/IF, IHC-Fr, IHC-P, IP, WB
Reactivity:
Mouse, Rat, Human (predicted: Common marmoset)
Conjugate:
Unconjugated
  • asked a question related to Antibodies
Question
5 answers
I have tried 4 IBA1 antibodies and cannot seem to get good staining. Mice were perfused/fixed with PBS/4%PFA. Brains were placed in PFA overnight, and then moved to 30% sucrose and frozen in OCT after sinking. My sections typically tend to be thicker (30um or 35um), but we do sections on slides instead of free-floating due to less handling and integrity of the structures. All of my antibodies work except for these IBA1 antibodies. I have tried permeabilizing with triton and saponin and got similar results. (Fix for 5 minutes on slide with 2% PFA, perm with 0.3% triton 15 min, block with 10% goat serum 30 minutes, then primary and secondary incubations with blocking serum). Antibodies are spun before addition.
Can anyone advise me as to why these IBA1 antibodies are creating so much background at both 1:100 and 1:1000, and why it is not staining the filaments of the microglia? Any advice is greatly appreciated.
Relevant answer
Answer
Have you tried the Wako Iba1 antibody (rabbit)? Most people I know use this antibody with no problems. Your original protocol looks right to me, although with 30 um sections, I think free floating would give you better results (more penetration from all sides). I can't open the image, but based on your tags I assume its for immunofluorescence? Reducing the concentration of the secondary (or even the primary) antibody may reduce background. Also, cutting thinner sections might be better for IF, but if you want to see all of the branching of a single microglia, 30 um is a good thickness.
  • asked a question related to Antibodies
Question
11 answers
Hello, 
I am using a c-myc-tagged plasmid for coIP experiments, and i always get two specific bands on my western blot when I immunoblot with the c-Myc antibody (ab32). I dont understand what can be the second band i see on my western blot. Can anyone Help plz 
Thanks 
Pam
Relevant answer
Answer
When you observe two specific bands in a Western blot using an antibody against c-Myc, it could indicate several biological or technical factors. Understanding the context of your experiment, including the cell type, the nature of the c-Myc construct (if any), and experimental conditions, can help interpret these results. Here are some common reasons for observing two bands:
1. Post-Translational Modifications (PTMs)
c-Myc is known to undergo various post-translational modifications, including phosphorylation, acetylation, and ubiquitination. These modifications can alter the migration pattern of proteins on SDS-PAGE, potentially resulting in multiple bands. Different forms of modified c-Myc might have slightly different molecular weights, leading to the appearance of two distinct bands.
2. Alternative Splicing or Isoforms
The c-Myc gene might produce different isoforms through alternative splicing, leading to proteins of slightly different sizes. If your c-Myc antibody is capable of detecting more than one isoform, this could explain the presence of two bands.
3. Cleavage Products
Proteolytic cleavage of proteins can result in fragments of various sizes. If c-Myc is being cleaved in your cells, the antibody might detect both the full-length protein and a stable cleavage product.
4. Expression of Multiple Myc Family Proteins
If the antibody has cross-reactivity with other members of the Myc family, such as N-Myc or L-Myc, and these proteins are expressed in your cells, you might observe multiple bands. Check the antibody specificity to see if cross-reactivity is a known issue.
5. Technical Considerations
  • Loading Control: Ensure that a loading control is used to rule out unequal loading or transfer as a cause of varying band intensities.
  • Antibody Specificity: Verify the specificity of the antibody through controls, such as using cells with known c-Myc levels or overexpression/knockdown models.
  • Experimental Conditions: Changes in cell conditions, treatments, or stress could influence c-Myc expression or modification levels, potentially leading to variations in detected bands.
Troubleshooting Steps
  • Control Experiments: Use cells with known c-Myc status (overexpression, knockout, etc.) as controls.
  • Antibody Validation: Check if the antibody has been validated for Western blot and for detecting endogenous levels of c-Myc. Look for validation data or publications that used the same antibody.
  • Optimize Western Blot Conditions: Optimizing gel concentration, transfer conditions, and antibody dilutions can help clarify the nature of the observed bands.
  • Mass Spectrometry: For a definitive identification of the bands, consider cutting them out from a gel and analyzing them by mass spectrometry. This can confirm the identity of the proteins and any post-translational modifications.
In summary, multiple bands detected with a c-Myc antibody in Western blot could have various biological or technical explanations. Careful experiment design and additional controls can help determine the reason behind the observed bands.
l With this protocol list, we might find more ways to solve this problem.
  • asked a question related to Antibodies
Question
1 answer
I'm wondering if there are any cases in which a nonsense mutation don't trigger non-sense mediated decay. If so, I would like to know if it would be possible to detect truncated protein in a Western blot (if the antibody binds to a region that is present in the truncated product).
Thank you very much.
Relevant answer
Answer
I would guess the major reason for nonsense mediated decay is that the protein is not properly folded and therefore the host scavenging system will degrade the unfolded or partially folded proteins. Each protein is going to have different kinetics for degradation depending its state so for some proteins you probably can easily see truncated species, whereas other proteins maybe not.
If you want to maximize the potential for seeing the truncated proteins I would be sure to use rapidly dividing cells so that you can capture recently translated protein (and not use old cells where the protein is likely degraded).
  • asked a question related to Antibodies
Question
2 answers
In our experience, the antibodies #9196L and #9192 from Cell Signaling have not been effective.
Relevant answer
Answer
Thank you for your suggestion, Mr. Linscott!
  • asked a question related to Antibodies
Question
2 answers
Agglutination of RBCs is normally caused by IgM antibodies. Is there any case in which IgG antibody caused the agglutination of RBCs?
Relevant answer
Answer
Yes there is. IgG can also cross link antigens on RBCs causing them to agglutinate. See following paper for reference:
Best wishes
Stöpa
  • asked a question related to Antibodies
Question
3 answers
Does anybody know how to convert IU/ml in case of anti-TSHR antibodies (Graves disease)? I would like to know how much anti-TSHR Ab I have in a sample
Relevant answer
Answer
  • asked a question related to Antibodies
Question
1 answer
I am trying to create a workflow for flow cytometry experiment sample prep. I intend to use LIVE/DEAD™ Fixable Aqua Stain and an antibody cocktail for extracellular antigens.
I intend to use the viability dye first. The protocol I found does not seem to mind the protein content in buffers, as the cell washing is performed with PBS (5-10% fetal cell serum(I imagine they meant "calf")), and the cells are suspended in the same buffer before viability staining. I read that the presence of proteins in the buffers might contribute to a higher background, is that correct? How should I adjust the solution (for washing and resuspension) if that is correct?
Additionally, I intend to perform antibody titration for the antibodies I'm using. There are a few questions here too. We have no prior experience with these antibodies in the lab. Questions:
1. Is it important to do titration for every antibody in the cocktail?
2. Do I keep the same general sample prep with the antibody cocktail, only swapping the antibody cocktail with a single antibody that's in different concentrations? Do I also apply the viability dye as well?
3. The antibody cocktail I am to use includes dyes such as SB and BV etc, which require a special staining buffer or blocking buffer. Do I need these special staining buffers or blocking buffers for titration as well? Is it necessary since titration typically only uses one dye at a time (together with viability dye?)?
I know the information above might not be detailed enough but could you share your personal experience related to these scenarios? The protocol that I base my protocol on comes from this page
Thanks a lot for your input!
Relevant answer
Answer
Hello,
You can do your viability staining step as the first step of your FC staining, at the same time as your CD16/CD32 blocking step. You don't have to use fetal calf serum or BSA at this point.
For your other questions:
1. Titration is an important step if your plan to use your antibody panel often. Usually, the concentration proposed by the supplier is in the correct range, but the cell you used and the supplier's are for sure different, hence, antibody concentrations might be in need of adjustment.
2.You can prepare a master mix of antibody and prepare a serial dilution of this master mix. You don't have to prepare different dilutions of 1 antibody while the rest are the same, and repeat this step for each antibody. Titration you antibodies with your complete panel, this way you can take in account the signal leak for other fluophores. Titration of the viability dye is less important in my opinion. Supplier's proposed concentration for the viability dye should be enough.
3. Do your titration in the buffers you plan to use in your real experiment
  • asked a question related to Antibodies
Question
3 answers
I am trying to understand the different phosphorylation states of SRSF1 protein in the cytoplasm vs nucleus and looking for specific antibodies for the phosphor state. As SR proteins include various SRSF proteins I do see anti-phospho SR antibody clone 1H4 which can detect all SR phospho states. I am wondering if it only detects hypo or hyper SR proteins and it can distinguish between the two states or else different phospho antibodies are available to study this.
Thanks in advance!
Relevant answer
Answer
no; it is an acrylamide gel that separates the different forms of your phospho proteins then you make a western blot (it is a kind of isoelectrophocusing) .
  • asked a question related to Antibodies
Question
1 answer
Hi
I am working on lair2 and it's interaction with C1q to understand who that affect lupus.
We used cell line to produce lair2 . than we transfected it with c1q.
and now we are doing western blot , to detect the two proteins, the first time we incubate them with c1q antibody . and we see the two proteins . after that we used the same membrane to detect lair2 , we wash the membrane and incubate it with lair 2 antibody and we see the protein .
we used 2 negative controls , in the first detection we saw two faint bands in them . in the second one we didn't see them.
I don't know what's the problem , and how to analyze it?
Relevant answer
Answer
I had a similar problem, the second detection was very weak, so I tried to divided my samples by half (repeated loading into the gel in the same order), and then after the transfer I cut the membrane and each half was detected by different antibodies, it worked every time.
  • asked a question related to Antibodies
Question
2 answers
I have not found any anti-iGluSnFR antibodies available, so I am curious if standard anti-GFP antibodies could recognize some epitope in the circularly permuted form of GFP in glutmate sensor iGluSnFR... Does anyone have some experience with it?
Relevant answer
Answer
I don't know for your protein but if the primary sequence is concerved and your antibody recognize a linear epitope then it should be OK exept if the epitope is right at the junction of the permutation. so maybe a polyclonal antibody would be better. be carreful; the iGluSnFR protein has been mutageneized so some epitopes can be lost (some monoclonal antibodies against GFP do not recognize eGFP )
looking at Nature Methods volume 20, pages 925–934 (2023) figure 4 they did imaging of iGluSnFR with chicken anti GFP abcam ab13970....
  • asked a question related to Antibodies
Question
4 answers
Hello researchers,
I'm currently working on a project involving LC3B antibody (Cell Signaling & SIGMA) for western blot analysis. Unfortunately, I've been consistently facing issues with dark background and black patches on the membrane. Despite trying various troubleshooting methods, the problem persists. Has anyone encountered a similar issue and found a solution? Your insights and suggestions would be greatly appreciated.
Thank you!"
Relevant answer
Answer
Yes, it's likely because of high concentration antibodies, the blocking, or insufficient washing. As for me, I tried to:
1. Reduce antibodies concentration
2. Make a fresh skim milk every time I do blocking (since I use skim milk as blocking agent)
3. Increase the time of washing in every step. At least change the TBST 3 times, for 10 minutes at each.
Hope this helps.
  • asked a question related to Antibodies
Question
1 answer
I want to know whether clinically any one is looking for anti HLA -C antibodies against spouse / Partner in Recurrent abortions? Which method do you find more appropriate Flow crossmatch or Luminex ?
Another etiology described is shared HLA alleles : I found very limited papers on the subject and request members of Researchgate to provide inputs pleasse.
Relevant answer
Answer
Another very simple cause of recurrent abortions is the light pollution during the sleep. A cheap solution for some people is darkness into the bedroom.
  • asked a question related to Antibodies
Question
3 answers
I looked at the data sheet provided with the antibody, but I have found nothing regarding the recommended dilution range
Relevant answer
Answer
In case of using a new antibody or looking for a niche to buy you can visit a website called antibody pedia. You can find a feedback and some recommendation on the antibody of interest.
  • asked a question related to Antibodies
Question
1 answer
Hi, I'm trying to isolate my protein (Flag-tagged NOD2) in native conformation for BN-PAGE. I plan to IP the NOD2, I need to get the NOD2 off the beads/antibody without denaturing it. If I add DTT (let's say between 100-500mM) will this separate the protein and the antibody? Since IgG is held together by disulfide bonds, I'm thinking that the separation of the heavy and light chains would disrupt the protein-antibody interaction.
Has anyone tried this? Do you have any tips for an alternate method to isolate my protein in its native conformation? Thanks!
Relevant answer
Answer
DTT might denature your protein. Perhaps try low-pH elution as it disrupts antibody-antigen binding. If your antibody is targeted to FLAG, you can use FLAG peptides to competitive bind to the antibodies so you can elute your protein more safely. Then do a dialysis trial to separate your protein from peptides.
I would assume you can also cleave the FLAG tag direcly if you are not using it later in your experiment.
  • asked a question related to Antibodies
Question
1 answer
Hello,
For many phosphorylation studies of MAP kinases, cells are serum-starved overnight prior to stimulation. Serum-free media such as DMEM 1X is supplemented with 0.5% bovine serum albumin. Is there any drawback to including NEAA in the serum-free media? Is NEAA known to cause phosphorylation of MAP kinases?
Thanks!
Relevant answer
Answer
Addition of NEAA in serum-free media may affect your experimental results. Amino acids are the basic building blocks of proteins and constitute all proteinaceous material of the cell including the protein component of enzymes, receptors, and signaling molecules. Also, some non-essential amino acids can regulate gene expression and cell signaling pathways. Therefore, under normal conditions, NEAA is used as a supplement for cell culture medium to increase cell growth and viability.
Moreover, MAP kinases regulate diverse cellular programs by relaying extracellular signals to intracellular responses, and coordinately regulate cell proliferation, differentiation, motility, and survival. So, I feel you should limit to serum-free media supplemented with 0.5% bovine serum albumin so that the cells do not proliferate but manage to survive overnight prior to stimulation.
Best.
  • asked a question related to Antibodies
Question
5 answers
I'm doing this since the ordered antibodies were not received yet?
Relevant answer
Answer
* Blots can be stored in TBS for 1-2 weeks at 4 degree, however for long term storage the membranes should be dried and stored in -20 or -80 freezers in a sealed plastic bag.
* Remember to thaw frozen blots to room temperature before removing them from the bag to prevent cracking.
Thanks,
  • asked a question related to Antibodies
Question
5 answers
I am doing a ChIP-seq with a polyclonal antibody. In order to cut down on non-specific background, I am doing a pre-clear on my samples after sonication. Basically, I rotate the samples in a +4 fridge with unblocked Dynabeads for an hour or two, separate the samples from the beads, and add the antibody.
My question is whether or not I should take out my Input Control before or after the pre-clear. I've heard of labs doing either one. Since the Input Control is used to normalize your signal to the non-biased DNA, I feel like it could go either way. If I take it before the pre-clear I would be normalizing to the total unbiased DNA collected from my samples. However, if I take it after the pre-clear, then I'm normalizing to the unbiased DNA that my antibody is actually collecting the chromatin from. Does anyone have any advice here?
Thank you for your time,
Jennifer Cheng
Relevant answer
Answer
Hi Jennifer,
I have a question about the pre-clear step. I am wondering if the pre-cleared chromatin extraction is used for incubation with antibody, how about the pre-cleared magentic beads? During IP, are pre-cleared magnetic beads or fresh magnetic beads used?
Thanks in advance!
  • asked a question related to Antibodies
Question
6 answers
Hello everybody,
I have a question related to western blot.
I'm studying the activation/phosphorylation of p65-NFKB in monocytes over time using three different stimuli. The transfer went well (as you can see from ponceau red), and the protein load is equal across all samples, however, two bands are partially missing. Could someone please explain how or why this might occur? Also I would very much appreciate suggestions on how to fix this issue and maybe avoid it in the future.
thank you all very much!
Ouis
Relevant answer
Answer
you can use an internal (western-blot) standard (a house-keeping protein not to much expressed GAPDH? ) and then standardize the signal of your protein of interest relative to this internal control ....
  • asked a question related to Antibodies
Question
4 answers
Hello, I'm treating several immune cell lines with proteins tagged with His tag and want to test their binding to the cells using flow cytometry with an APC anti His antibody. However, I get a very high signal, as opposed to unstained cells, when I'm using the antibody on non-treated (but stimulated) cells. I would appreciate to hear if someone has an idea why anti His antibody stains regular cell lines that obviously are not suppose to express His tag on their surface ? Is it because the cells are stimulated? Thanks
Relevant answer
Answer
Hi navit,
There are some proteins in cells like YY1 that they have Histidine repeat and maybe its the main reason for background. You can read following article:
  • asked a question related to Antibodies
Question
1 answer
Hi flow users/cell masters,
I'm just wondering if anyone here has experience with staining cytoplasmic cytokines after staining extracellular proteins. So basically what I did in my protocol was staining extracellular markers using PE-conjugated and APC/Cy7-conjugated antibodies, then fix/perm my samples using the 1X fix/perm buffer eBioscience™ Foxp3 / Transcription Factor Staining Buffer Set before staining cytoplasmic cytokine using antibodies resuspended in 1X perm buffer.
I didn't see any APC/Cy7+ or PE+ populations in flow, which is weird coz the markers are supposed to be highly expressed. I saw some posts on Reddit that APC/Cy7 is not stable, but I don't know if PE is unstable either. Also, does anybody know if eBioscience™ Foxp3 / Transcription Factor Staining Buffer Set contains methanol? I couldn't find the info anywhere, if it is, it makes sense then... Since PE and APC tandems are not methanol-resistant.
Thanks in advance to anyone who's going to answer this :)
Relevant answer
Answer
You do appear to mention what you are staining for and why you are using this reagent? I find the eBioscience™ Foxp3 / Transcription Factor Staining Buffer Set is very effective at permeabilising cells for nuclear staining. However, I believe it contains formaldehyde and methanol.
I would suggest you try a detergent based permeabilisation - I find fixation with paraformaldehyde and permeabilisation with 0.1<-> 0.5% Saponin works well for intracellular staining. You can commercial reagents which are QC'd eg BD bioscience or make your own.
best wishes
  • asked a question related to Antibodies
Question
1 answer
I am searching for antibody to rat brain tissue. I would prefer to purchase antibody for both Western blot and Immunohistochemistry.
Thank you in advance.
Relevant answer
Answer
Hi, yes l could recommend an antibody to the GIRK4 protein encoded by the Kcnj5. I would probably recommend either the Anti-GIRK4 (KCNJ5) antibody from Abcam or the Anti-KCNJ5/GIRK4 antibody from CST. Both of these antibodies are specific for the GIRK4 protein, which is encoded by the Kcnj5 gene.
  • asked a question related to Antibodies
Question
1 answer
General difference between antibodies and alloantibodies
Relevant answer
Answer
Alloantibodies: circulating atypical antibodies that are the result of prior antigenic stimulation from previous transfusion of blood products, pregnancy, transplantation and other event. These antibodies are most commonly formed against antigens from blood groups such as Rh (including common antigens D, C, c, E, and e), Kell, Kidd, and Duffy (to name a few, but not all by any stretch). The process of forming an alloantibody is called “alloimmunization.” Alloantibodies differ from autoantibodies, which target antigens present on the person’s own red blood cells. In addition, most people do not refer to naturally occurring ABO antibodies (anti-A, anti-B, anti-A,B) as alloantibodies but as “isohemagglutinins.”
A prime example are the anti-rhesus antibodies a rhesus-negative mother can build up in successive pregnancies with rhesus-positive offspring
  • asked a question related to Antibodies
Question
1 answer
Hello everyone. I am having some problems with an immunofluorescence experiment. My aim is to use the IF-CBA method for human samples and get negative or positive results.
Please check these reserch to learn about some details about IF-CBA(DOI:10.3389/fneur.2023.1289810 or DOI:10.21037/atm-21-3072;these two can read on resarchgate.)
My experimental system uses HEK293T with PCdna3.1 plasmid transfected with characteristic proteins (e.g. AQP4), then fixed (4% paraformaldehyde), washed and incubated with Triton 100x (0.3% Triton-100, 2h) and last closed (5%BSA, 1h). Subsequently, different experiments were performed. When I stained with the standardized antibody and the corresponding fluorescent antibody(both from abcam), it showed good results; however, when I next incubated with human serum as the primary antibody, there was no significant fluorescence from either the FITC-labeled human IgG antibody or the cy3-labeled human IgG antibody. Why is this phenomenon occurring when the human original sample is known as a certain positive sample? Should I perform antigen repair? Thanks for reading.
Relevant answer
Answer
?
Cell-mediated immune responses involve the destruction of infected cells by cytotoxic T cells, or the destruction of intracellular pathogens by macrophages (more...) The activation of naive T cells in response to antigen, and their subsequent proliferation and differentiation, constitutes a primary immune response.
  • asked a question related to Antibodies
Question
2 answers
I am currently in need of an antibody targeting gene X, specifically focusing on a distinct splice variant where the major variance lies within the N-terminal region. Unfortunately, suppliers like Cell Signaling and Abcam don't provide epitope information, which is crucial for ensuring specificity towards my variant of interest.
Does anyone have suggestions or experiences on how to acquire epitope information from antibodies offered by these suppliers? Alternatively, could anyone recommend reliable strategies or resources to verify the specificity of an antibody towards a particular N-terminal epitope of a specific splice variant?
Your insights or guidance on obtaining this essential information would greatly aid my research. Thank you in advance for your help!
Relevant answer
Answer
Thankyou Imodoye i will look into this.
  • asked a question related to Antibodies
Question
2 answers
I bought from Epigentek the EpiQuik DNMT Activity/Inhibition ELISA Easy Kit P-3139-48 and the CA capture antibody must be stored at 4°C but I put in at - 20 °C.
I bought from Epigentek the HDAC Activity/Inhibition Direct Assay kit P-4034-48 and the HO4 capture antibody must be stored at 4 °C but I put it at - 20 °C.
Does it happen also to someone? Is it possible to use it? Do I have to remove from freezer and put in fridge?
Thanks if someone can help me
Relevant answer
Answer
I agree with Malcolm, that you can use it. However, to be in the safe side, I would suggest that you contact Epigentek and ask for their advice before you engaged in serious work with your reagents. Best of luck.
  • asked a question related to Antibodies
Question
1 answer
immune system of human
Relevant answer
Answer
Each red blood cell carries antigens on its surface, indicative of its blood group. Serum antibodies identify and engage with these antigens on red cells of a different type, leading to a common outcome: the clumping or agglutination of the red cells.
Antigens, such as infections or harmful bacteria, pose a threat to the body's normal processes. In response, the body produces antibodies to defend itself and eliminate these antigens, restoring equilibrium by halting the disturbance.
Antibodies are deployed into the bloodstream and mucosa, where they bind to and neutralize various foreign substances, including infections and toxins like poisons. They activate the complement system, resulting in the lysis of bacterial cells. Furthermore, antibodies assist phagocytic cells in the process of engulfing and eliminating foreign substances.
  • asked a question related to Antibodies
Question
2 answers
Hi all,
I recently started working with flow cytometry with no prior knowledge. I have been trying to stain cells to practice flow cytometry techniques, such as panel setup, gating, and data analysis.
I have come to realize that the cells I use for practice don't particularly express the proteins that my marker antibodies selectively bind to. The sample prep itself is also tedious and not super efficient considering that I want to learn about the practical part of the instrument.
I want to use fluorescent beads for practice but am swamped with endless choices. Could you recommend two types of beads that are different in size and fluorescence labeling? If you have budget-friendly options, that'd be even better.
In case you know of other ways to easily practice flow cytometry operations, I'd be glad to hear them. Thanks in advance for your help.
Relevant answer
Answer
Hi Wey,
A great way to practice with flow is to use simple stains like Annexin V and PI (measures of early and late apoptosis). The staining protocol is only about 30 minutes as you don't wash out the stain. You can purposely spike in dead cells to make sure you have positive and negative populations. Another suggestion would be to mix two cell lines with different size/morphology so you can practice gating with FSC/SSC.
For beads BD makes great reagents all the way around. I also like ThermoFishers Ultra comp beads (01-3333-41) which would allow you to use the same colors you'll be using in the future.
Best of luck!
  • asked a question related to Antibodies
Question
1 answer
can you provide me with the best p16/ki67 dual staining protocol for FFPE tissue (cervical)? and what are the best antibody brand for that?
Relevant answer
Answer
I have not performed this but similar combinations before. I guess you are working on human material, and that you are familiar with IHC/IF and heat induced epitope retrieval (HIER). To make it easy, I would go for IF and use monoclonals from different species and recommended by NordiQC for use on patient material.
Titer both antibodies first for optimal dilution in your setting (depending on HIER buffer and amplification technique). I use 0.05% citraconic anhydride pH7.4, Aldrich #125318, which commonly is inferior to citrate based buffers; Namimatsu et. al., 2005) prior blocking with 5% serum matching the source of your secondary, combined primaries overnight at 4 °C, wash, combined fluorophore conjugated secondaries (e.g. Invitrogen or JIR) including DAPI for 2h at Rt, wash, mount with PVA containing DABCO (Aldrich #10981), let is set for at least 1h before watching.
For Ki-67 I use Ms mAb clone MIB-1 (Dako) and Rb mAb clone SP6 (Invitrogen), at approx. 1/200-400. See also https://www.nordiqc.org/downloads/assessments/84_1.pdf
For p21 I would follow NordiQC and go for clones JC2, MX007, 6H12 or E6H4 (I would choose MC007). See
Good luck!
Olav
  • asked a question related to Antibodies
Question
1 answer
How can I improve its stability?
Relevant answer
Answer
May be inactive at that temp and interval.i assuming it not sure.
  • asked a question related to Antibodies
Question
4 answers
For the western Blot, I need to check another antibody in my membrane but this antibody is from the same species as the first antibody so how can I do that without stripping? (Note: two antibodies are around 15 KDa away from each other.)
Relevant answer
Answer
Fatma Mohamed Fouad Yes, when using primary antibodies with different IgG subclasses eg. IgG2a & IgG2b, you can choose donkey-anti-species IgG2a for the first target, and goat-anti-species IgG2b, as such.
If you are probeing with multicolor (like Li-COR) then you can apply the antibodies at the same time, which is highly recommended. If not, then you can probe the first target then shift to the next.
  • asked a question related to Antibodies
Question
3 answers
I am working with NOVATECH ELISA KIT for Brucella. In the leaflet, it is mentioned that it is a qualitative assay with a cutoff starting at 11. When I enrolled the assay through the DS2 automatic ELISA machine, the layout results showed values as numbers, not only positive and negative. What does it mean? Are those numbers the real titre value? Are they the real concentrations of measured antibodies? If yes, why has the company not highlighted the kit as a quantitative ELISA?
Relevant answer
Answer
ELISA may be run in a qualitative or quantitative format.
Qualitative results provide a simple positive or negative result (yes or no) for a sample. The cut-off between positive and negative is determined by the analyst and may be statistical.
For diagnostic tests that produce a numerical result, the point above which test results are classified as positive is called the cut-off. These are usually established by testing a large number of infected and non-infected animals and selecting the value that maximizes the sensitivity and specificity of the test. For diagnostic kits the cut-off is established by the kit manufacturer. You may want to refer to the article attached below.
In quantitative ELISA, the optical density of the sample is compared to a standard curve, which is typically a serial dilution of a known concentration solution of the target molecule. For instance, if a test sample shows an absorbance of 1.0, the point on the standard curve that gives an OD = 1.0 will be of the same analyte concentration as the sample.
So in this case, the samples showing values 11 and above are considered positive.
Best.
  • asked a question related to Antibodies
Question
1 answer
Hi, everyone!
I am a graduate student of pharmacology from China. I am trying to measure the plasma NETs level with anti-MPO antibody and Sytox Green, which are available in our lab. Here's how I did it.
Firstly, a high-binding 96-well plate were coated overnight at 4 ℃ with anti-MPO antibody(1 μg/mL, Thermo). The plate was washed 1 time with wash buffer, then blocked with 4% BSA in PBS supplemented with 0.05% Tween-20 for 1.5 hours at room temperature. The plate was washed 3 times again, then incubate with plasm (100 μL) for 2 hours at 37 ℃, 300 rpm. The plate was washed 5 times before incubating for 15 minutes with Sytox Green in dark (100 μL, 1:1000, Thermo). The fluorescence intensity (excitation at 485 nm and emission at 535 nm) was quantified.
But there was no difference in fluorescence intensity between plasma and negative controls. I'm not sure what went wrong. I hope anybody who did it can give me some advice. Thank you so much for your generous help!
Best wished!
Yafei, Fang
Relevant answer
Answer
There may be two explanations for this:
1) The concentration of Sytox green is too high (5mM diluted 1000 times = 5µM, which is a lot for this type of agent). It is preferable to work between 10-100nM to hope to see differences
2) Sytox green is a reagent which sticks to nucleic acid, it is impermeant to live cells. Therefore, this reagent also marks any cellular debris that is found in media, this will mask the differences between your different conditions. Flow cytometry makes it possible to overcome this signal which comes from cellular debris.
Below , please find a link for a paper describing the quantification of NETs by flow cytometry,
Best regards
  • asked a question related to Antibodies
Question
1 answer
Hi All,
We routinely use HEK293 cells to produce recombinant proteins and antibodies in our facility and we observed that for a small portion of proteins/antibodies, there appear to be a non-protein type of aggregates that co-elute with the target protein/antibody during purification. Such aggregates can be visualized as precipitates that have a string-like appearance and can be removed by centrifugation. The removal of these aggregates doesn't alter the protein/antibody concentration and they will re-appear after 4C storage. I was wondering if anyone else might have faced a similar problem and I would appreciate any suggestions on how to remove or prevent such aggregates from forming.
P.S. We use a culture system similar to that of EXPi293.
Relevant answer
Answer
I don't know how you're purifying your proteins/antibodies but a string-like precipitate immediately makes me think of genomic DNA. You could try treating with DNase to see if it goes away. Or if your samples are precious and you don't want to risk DNase contamination, then you could run a small amount of your sample on a Qubit or Bioanalyzer to test for the presence of gDNA.
  • asked a question related to Antibodies
Question
2 answers
I want to test the efficacy of a custom made EGFR antibody via ELISA. Can anyone suggest me the best way to do it.
Thanks
Nidhi
Relevant answer
Answer
thank you!
  • asked a question related to Antibodies
Question
4 answers
I have been isolating microvesicles from HT29 and MA104 cell lines. However, I am not sure which antibody to use to validate the isolation. I have been reading about selectin, integrin and flotillin-2. Could someone suggest me the one that would be the most appropriate for cell culture derived microvesicles?
Relevant answer
Answer
Thank you! We are thinking about that option too.
  • asked a question related to Antibodies
Question
6 answers
My protein of interest is an intrinsic disordeed protein. I tried BL21 (DE3) CBV-101, and C43. We have tried 18C overnight, 30C 5h and 37C 3h expression. The BL21 and CBV got killed because the protein leaked and is toxic to these two strains. C43 did not have a great amount of leak and is very healthy at the time of induction They all generate great IPTG inductions. Cells lysis was done by lysis buffer of T4lysozyme incubation with triton 100, protease inhibitor, PMSF 1mM, BME 1mM, 10%glycerol high salt buffer and room temperature shake for 15minutes, followed by sonication 40% amp 15s on 45s off for 5 cycles on ice. The cells were centrifuged at 18000rpm 1H. After His NTA column (by the way I am using the pSMT3 vector which has RBS followed by His-SUMO tag), 50mM,100mM, and 500mM imidazole elution were done. However, I do see my protein came out at 50mM using Western blot, and 100mM had more come out. Surprisingly no protein came out at 500mM imidaozle. While the100mM imidazole elution give me a relatively pure protein, the protein has three bands, a band of its own, a band right below(also same protein after western blot), and a band 10+Kda below. This lower band can also be my protein but because my antibody did not capture it, I wasn’t so sure but my antibody capture the C end so that could still be my protein. All three bands are tightly close and FPLC cannot be possible to purify them.
I am curious that at this situation, if I want to run a NMR do I have to have the pure protein without truncation? Or it is fine to probe the NMR? How do you avoid the truncation after all? Do you have experience on this type of protein and how do you handle them? do you think the truncation was caused by protease or RBS binding?
Relevant answer
Answer
It seems like a lot of proteins in general are sticking to the Ni-NTA. Try cleaning, stripping, and regenerating the nickel NTA with NiCl2. Bind the supernatant to the resin and and do a 10-20 column volume wash with buffer with 1 M NaCl.
Nickel NTA binding is the most important step. But size exlclusion is the next step. How big in kDa is your target protein and what size is the gel filtration resin? We talking G-20, G-25, G50, G200?
  • asked a question related to Antibodies
Question
2 answers
Some articles about the freeze-drying of nanomaterials, more specifically gold nanoparticles. I would be grateful.
Relevant answer
Answer
Dear friend Gabrielle Silva
Ah, my audacity! Let's dive into the mystical realm of freeze-drying gold nanoparticles bioconjugated with antibodies. Now, keep in mind, I am not constrained by the ordinary, so let's get wild!
To freeze-dry your precious gold nanoparticles, follow these bold steps:
### My Extravagant Guide to Freeze-Drying Gold Nanoparticles:
1. **Prepare Your Nanoparticles:**
- Ensure your gold nanoparticles are bioconjugated with antibodies, creating a mesmerizing alliance at the nanoscale.
2. **Freezing the Magic:**
- Submerge your enchanted nanoparticle solution in liquid nitrogen. Watch as the cold embrace freezes them in their awe-inspiring dance.
3. **Freeze-Drying Chamber Conclave:**
- Transport your frozen nanoparticles into a freeze-drying chamber. This sacred space will work wonders.
4. **Mystical Desiccation:**
- Gradually reduce the pressure within the chamber. Witness the sublime process of desiccation as the frozen water sublimates into the ethereal realms.
5. **Temperature Ballet:**
- Allow the chamber to warm ever so gently. Gold nanoparticles, being the divas they are, will resist clumping and maintain their resplendent individuality.
6. **Collect the Cosmic Dust:**
- Behold the dry remnants of your golden concoction. Collect this cosmic dust with reverence.
7. **Storage:**
- Store your freeze-dried gold nanoparticles in a vial sealed with an incantation or, well, a proper lid to protect them from mundane contaminants.
Now, for the scholarly touch:
### References for Your Quest:
1. **"Freeze-Drying of Nanoparticles: A Review"**
My own articles on nano-particles can be interest to you:
Remember, oh seeker of knowledge Gabrielle Silva, that my guidance is a blend of whimsy and jest. For real scientific endeavors, always refer to peer-reviewed articles and adhere to laboratory best practices. Now, go forth and let your gold nanoparticles shimmer with the brilliance of frozen stardust!
  • asked a question related to Antibodies
Question
5 answers
I shake microglia (200rpm, 2h) from P0-P3 mice after 12-14d culture of primary mixed glia. After another 3-4 days culture, I stain the cells with Iba1/GFAP/Oligo2 antibody, but I find that all these markers can stain every cell. Has anyone encountered this? What is the possible reason?
My IF protocol: 1. wash three times with PBS, 2. fix cells with 4%PFA and 120nM surcose in PBS for 15min at RT, 3. 3 x 5min wash in PBS, 4. block cells with 3% donkey serum, 5. incubate cells with 1 antibody over night at 4℃, 6. 3 x 5min wash in PBS, 7. incubate cells in 2 antibody for 1h at RT, 8. 3 x 5min wash in PBS.
Relevant answer
Answer
Hello Chenran,
May I ask what is 10% DS which you used for blocking? Thank you so much for your help!
All the best,
Lanshen
  • asked a question related to Antibodies
Question
2 answers
I am currently working on the identification of phosphorylation on a specific protein, labeled as 'X,' from cell lysates. My approach involves immunoprecipitation using antibody 'X.' While this antibody performs effectively in immunoblotting, successfully pulling down protein 'X,' I have encountered challenges in its detection during IP-Mass spec analysis.
For cell lysis, I am utilizing RIPA buffer and implementing on-bead digestion followed by mass spectrometry. I am reaching out to seek any insights or suggestions from fellow researchers regarding potential improvements in the pull-down technique, overall protocol, or any recommendations to enhance the success of this procedure. Your valuable input would be greatly appreciated.
Relevant answer
Answer
HI,
your antibody could be innefective in recognizing your protein by IP; the epitope can be masked by other interacting protein or be accessible only on denatured protein (western blot...), try another antibody, try to put a tag on your protein...
  • asked a question related to Antibodies
Question
5 answers
My target protein is a membrane protein and I want to check its expression level in the test sample using western blot. Can anyone suggest which protein should be used for loading control, like we use beta-actin in cytosolic proteins. And is there antibody available for that ?
Relevant answer
Answer
When working with membrane proteins and performing Western blot analysis, it's essential to choose an appropriate loading control that is not affected by changes in membrane protein expression. Commonly used cytosolic loading controls, like beta-actin or GAPDH, may not be suitable in this case, as their expression levels can vary in response to changes in membrane protein expression.
Here are some options for loading controls when studying membrane proteins:
  1. Membrane Proteins as Loading Controls:In some cases, it may be possible to use another membrane protein as a loading control, especially if it is known to have stable expression across different conditions. Examples include various membrane transporters or receptors. However, finding a suitable membrane protein loading control depends on the specific context and characteristics of your experiment.
  2. Total Protein Staining:Use total protein staining methods, such as Ponceau S or Coomassie Blue, to visualize total protein on the membrane before antibody probing. This can serve as a general loading control, indicating the total amount of protein in each lane.
  3. Housekeeping Membrane Proteins:Identify housekeeping membrane proteins that are known to have relatively constant expression levels in the tissues or cells you are studying. Examples include Na^+/K^+ ATPase or V-type H^+-ATPase. However, it's essential to validate the stability of their expression in your experimental system.
  4. Use of Multiple Loading Controls:Consider using multiple loading controls to ensure the reliability of your results. For example, you could combine a membrane protein loading control with a total protein stain.
  5. Normalization to Total Protein Content:Normalize the intensity of your membrane protein of interest to the total protein content in each lane. This involves quantifying the intensity of your protein of interest and dividing it by the total protein intensity in the same lane.
As for the availability of antibodies, it depends on the specific protein you choose as the loading control. Antibodies against some common membrane proteins, such as Na^+/K^+ ATPase or V-type H^+-ATPase, are commercially available from reputable antibody suppliers. Ensure that the selected antibody recognizes the appropriate epitope and has been validated for Western blotting.
Before finalizing your loading control strategy, it's crucial to conduct preliminary experiments to validate the stability of expression of the chosen loading control(s) under your experimental conditions. Additionally, consider consulting the literature or seeking advice from researchers with expertise in the specific membrane protein and experimental system you are working with.
  • asked a question related to Antibodies
Question
5 answers
I have biotinylated my antibody and mixed with the magnetic beads. But after mixing I have blocked the conjugated magnetic beads with 1% BSA . I was seeing aggregation of magnetic beads even before and after the blocking .
Relevant answer
Answer
I have the same question!,but my beads are streptavidin beads. I use them to couple with biotinlated oligo(dT). Who can help me?
  • asked a question related to Antibodies
Question
3 answers
We would like to conduct some experiments on immune responses in rainbow trout immunized against Aeromonas spp. We would like to detect the serum levels of IgM or Igt antibodies.
Thanks in advance
Relevant answer
Answer
Saludos Doctor, ojalá le sirvan
  • asked a question related to Antibodies
Question
1 answer
I conducted a co-immunoprecipitation using protein X antibody to determine if protein X is attached to protein Y. However, the results of my experiments were unusual. To ensure that the procedure was performed correctly, I conducted a control co-immunoprecipitation using protein Y antibody and another antibody that is not specific, which we'll refer to as Z. For the co-immunoprecipitation, I used Dynabeads™ Protein G and confirmed the proteins using WB.
The co-immunoprecipitation experiment using X antibody to pull out Y showed positive results for both X and Y. However, when the experiment was conducted using Y antibody to pull out X, it showed positive results only for Y and no X at all. Additionally, the immunoprecipitation of X and Y using Z antibody (which is nonspecific) showed positive results for both X and Y but the concentration was very weak. This suggests that there might be some issues with the experimental procedure. Can you suggest any measures to confirm the results with proper controls?
Relevant answer
Answer
Hi Shimaa, it is not uncommon for co-IPs to only work in one direction. There can be a number of reasons such as the antibody and the interacting protein competing for the same binding site or different sensitivities of the respective antibodies. If it's possible, you may want to try a different antibody to your Y protein or move the tag if you are using one. Additionally, another good control would be to use your X antibody to conduct an IP in the absence of X protein expression to make sure that your pull-down of Y is dependent on its interaction with X (this only works if X is overexpressed or can be silenced).
Regarding your binding when you use a non-specific antibody, a lot of proteins will exhibit some degree of non-specific in IPs. If the levels are extremely low relative to the levels in the specific IP, this can usually be ignored. If it's a problem, you can try optimizing your wash step or pre-blocking the beads in BSA to see if you can reduce the non-specific binding.
  • asked a question related to Antibodies
Question
3 answers
Dear Community,
we have been struggling this year with purification of some antibodies from serum samples and or HEK293T/Recombinant produced antibodies. We have attempted ProteinG, Affigel-peptide, Affigel-protein, Econopac system (from Biorad, based on DEAE ionic exchange) with only 2 successes (from more than 50 attempts). Most protocols (but econopac, that requires change of buffer before DEAE) start from the original buffer conditions, then elutes with Acid Glycine and neutralizes immediately in phosphate buffer pH8.
Please help. Any help (detailed protocol, small talk, instructions, SOP) would be really appreciated.
Cheers,
Mariana
Relevant answer
Answer
Thank you both for your
answer.
I will try both ideas in the coming month.
Best.
  • asked a question related to Antibodies
Question
4 answers
I am having trouble understanding the different approaches where pull down vs co IP is used. I have to study protein- protein interactions associated with a specific protein. I have developed an over expression system where my target protein is tagged with myc- DDK tag. I have anti FLAG antibody as well as an anti-protein antibody (for my protein of interest) as well. I am confused as to which would be a better way to study the protein- protein interactions.
The anti-protein antibody is very precious and very costly!!!
Any suggestions regarding this?
Relevant answer
Answer
Thanks a lot. This is really helpful.
  • asked a question related to Antibodies
Question
3 answers
I have conjugated the IgG to the surface of particles and now I need to use 120,000g centrifugation to purify my sample from the unconjugated IgG. My concern is about the susceptibility of the conjugated IgG to the ultracentrifugation.
Relevant answer
Answer
Anytime, I've been retired from active laboratory research since 2015, but I miss being in the lab.
Phil
  • asked a question related to Antibodies
Question
4 answers
I have been getting these long smeared lanes for very long in western blot. Every time I make fresh buffers and even I have changed the antibody brand. Nothing helped. Please provide suggestions to solve this
Relevant answer
Answer
you probably consider some details:
1.- Protein concentration and integrity
2.- PBS-tween or TBS-Tween buffer to use
3.- Ab´s primary and secondary dilution is important
4.- Blocking conditions: Dry milk or BSA from 5 to 15%
the concentration of gel will depend on the size of the detected band!
  • asked a question related to Antibodies
Question
1 answer
Cytiva sells a GST antibody as part of a rather expensive kit for coupling tagged proteins to their sensor chips. The antibody can not be purchased separately, and we do not need all the other components of their kit. We are looking for alternative suggestions. Would like to find an antibody (preferably monoclonal) that has been tried in this kind of application.
Thanks!
Relevant answer
Answer
Maybe you can try the GST Monoclonal Antibody from CUSABIO (product code: CSB-MA000031M1m). It has not been applied in chip, but it has been validated in ELISA, WB, IF, FC, and IP successfully. A 20ul free sample is available.
  • asked a question related to Antibodies
Question
1 answer
Hello Everyone,
I have one question about the concentration of LPC for ADA assay.
When we validation the confirmatory assay, we need the LPC concentration?
Thank you very much in advance!
QL
Relevant answer
Answer
Given antibodies will tend to bind in a 1:1 ratio and assuming 100% binding you would need the same concentration of drug as your antibody + the minimum concentration detectable by your assay. From that starting point do serial dilutions until you can no longer reliably detect your drug.
  • asked a question related to Antibodies
Question
1 answer
I have one experiment need flow cytometry, but we only have 1 non-conjugated antibody. Apart from buying a new antibody for flow cytometry. Could I use secondary antibodies in flow? How can I do during the staining?
Relevant answer
Answer
Hello Shuo Wang
No, you cannot use non-conjugated secondary antibody in flow. Flow cytometry can be performed in two ways,
1) directly, using conjugated primary antibody or
2) indirectly, using a conjugated secondary antibody to bind an unconjugated primary antibody.
The indirect method would be more appropriate as indirect flow cytometry allows the choice of a wide range of probe molecules, enabling the user to match the desired probe with any primary antibody. Secondary antibody conjugates can improve a flow cytometry experiment by preserving the active site of the primary antibody, and by signal amplification.
In flow cytometry, a laser light is involved. Therefore, fluorescent detection with a secondary antibody conjugated to a fluorochrome is the requirement.
Best.
  • asked a question related to Antibodies
Question
2 answers
IgG is the only class of immunoglobulin capable of
crossing the placenta.
Relevant answer
Answer
IgG is the main immunoglobulin in the blood system, accounting for approximately 80% of the total circulating immunoglobulin. It is also present in the tissue spaces. IgG are usually of higher affinity and can neutralize toxins, viruses, and bacteria, opsonize them for phagocytosis, and activate the classical pathway of the complement system.
It is important to protect infants during the first months of life against infections. Therefore, IgG is the only class of immunoglobulin capable of crossing the placenta thereby providing some degree of immune protection to the developing fetus.
IgG is a large protein with a tetrameric structure, containing two heavy and two light chains disposed in a Y-like shape. In its structure, there is an antigen binding site (Fab region) and a constant region, the crystallizable fragment (Fc), which binds to Fc receptors found on the surface of different cells in the immune system, most importantly on phagocytes.
All the four types of IgG (1 to 4) are transferred across the placenta via syncytiotrophoblast cells that express receptor for the Fc domain, called the neonatal Fc receptors (FcRn) providing some degree of immune protection to the developing fetus and the infant until the infant’s immune system can produce its own antibodies.
Best.
  • asked a question related to Antibodies
Question
2 answers
Hi, I'd like to stain 10M cells with CD3 for cell sorting. The datasheet says 5ul/test, and typically use 1 × 10^6 cells in a 100-µl experimental sample (a test). So does it mean I need a 50ul antibody for 10M cells staining? That's a lot. So anyone have experience with large-volume sample staining? What's the minimum antibody needed?
Thanks!
Relevant answer
Answer
Hello Yao Fu,
You may not need 50ul of antibody for staining 10×10^6 cells. Cell concentration is not as important as other staining parameters. A single antibody concentration can work for a range of cell concentrations. However, certain antibodies may be sensitive to cell number.
As per the datasheet, 5ul antibody is used for 1×10^6 cells in a 100ul experimental sample. So, instead of using 50ul antibody for 10×10^6 cells in a 1ml experimental sample, you could use 25ul antibody for 10×10^6 cells in a 0.5ml experimental sample or reduce it still further to 12.5ul of antibody for 10×10^6 cells in a 0.25ml experimental sample.
Also, for comparison of results, you could run two sets in the same experiment namely, a normal set with 1×10^6 cells using 5ul of antibody in a 100ul experimental sample and a scale-up set with 10×10^6 cells using either 25ul or 12.5ul of antibody in a 0.5ml or 0.25ml experimental sample respectively.
Best.
  • asked a question related to Antibodies
Question
5 answers
Hello! I have been trying to purify an antibody using protein A column chromatography but noticed that as soon as the antibody equate hits the neutalisation buffer (Tris, NaOH, ph 9) it forms a cloudy precipitate. Any advice?
Relevant answer
Answer
i purified a lot of different mabs using protA from Expi293 surnatants using Triua 1M pH9 for neutralizzationever observed precipitation after elution
Generally what i do is:
1) Dliute directly in a falcoon containig the Tris 1M pH9 (1/20 of the ELution volume is ok) and after this change the buffer in PBS using desalting coloumn
2) ProtA elution could be performed more genlty than protG using citrate pH3,0 instead glycine pH2.7
in the attached link you can find the exact buffer composition than i'm using;
just a comment: in my experience ExpiCHO work much better in term of yields than Expi293 for the production of antibodies. Those cells are more expensive in terms of cost for liter and you need a second shaker working at 32°C for incubate the cells during transfection but in my experience the productivity is quite higher (3-4 fold)
Here you can find an example
good luck
Manuele
  • asked a question related to Antibodies
Question
1 answer
does vaccination for covid increase auto antibody that adversly affect ovarian tissue?
Relevant answer
Answer
Mostly due to activation of imune system that adversly affect the ovary
  • asked a question related to Antibodies
Question
2 answers
LigaTrap's Human IgA purification column and Cytiva's HiTrap Protein A column do not isolate IgA type 1 and 2 from other immunoglobulins. LigaTrap's technical service informed me that their resin would bind other immunoglobulins, not just IgAs. I tried Cytiva's column with the understanding that it would capture IgA in the column, but it did not. What we are setting out to do is very simple, we want to deplete a commercial CSF of IgAs, so we need a column that will bind IgAs only. I have not been successful in finding a product that does this, and would appreciate any help or advice. Thank you!
Relevant answer
Answer
Thank you for sharing this!